Helus Pharma Inc. (HELP)

$7.73 -1.24 (-13.82%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 864,772
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders. The company' preclinical product includes HLP005, a phenethyla...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 764 8385
Address:
100 King Street West, Suite 5600, Toronto, Canada
BloomBoom
BloomBoom Sep. 20 at 2:25 PM
$HELP Zero washout w/ a max 2hr treatment window vs 6 in cmps & required togo cold turkey off old meds. half the market cap of $CMPS and up only 100% ytd vs cmps @200% ytd. only a wouldn’t know how to play this one.
3 · Reply
RuddyRolls
RuddyRolls Sep. 20 at 2:34 AM
$CMPS $HELP @Millionaire11 @putINwork Thanks Brad, Emily, Alan Watts, Edward De Bono, Terence McKenna & The Mushroom! "The western mind is highly trained in rational, dualistic thinking, a lineage that traces itself all the way back to the ancient Greeks. Dualistic thinking is about comparison, differentiation, and splitting apart; in essence, it views the world as either this or that. It is an extremely important quality—one that underlies modern science and all the awesome, life-enhancing discoveries it has bequeathed us. But dualistic thinking is not the way only way to make sense of the world. And when it is applied to everything, we tend to run into problems. Some things in life truly are either-or, but many are both-and. Ancient wisdom traditions such as Buddhism and Taoism understand and teach the paradoxical nature of reality. They develop a non-dual mind." https://thegrowtheq.com/a-new-way-of-thinking-not-either-or-both-and/ https://www.carrienassifphd.com/blog/bothand
2 · Reply
JusaVaan
JusaVaan Sep. 19 at 9:55 PM
$CMPS $HELP I believe you are wrong about $HELP 2-hour clinic time. $ATAI 5-meo-dmt has a 2 hours clinic time. I believe $HELP has said it could be about 4 hours.
1 · Reply
Millionaire11
Millionaire11 Sep. 19 at 7:52 PM
$CMPS I’m sorry for getting argumentative. I want everybody to make money. I just like sharing my DD. I believe $HELP will do just fine. $CMPS is my bet and to me it is the obvious choice and i like to share my logic. I could be very wrong. In the end of the day our silly debates on stocktwits will not move the stock price. I wish everybody the best and good luck @putINwork I think you will do just fine in $HELP let’s win together.
2 · Reply
Millionaire11
Millionaire11 Sep. 19 at 7:38 PM
$CMPS $HELP I posted an article from their trial. Here ill post it again. https://ir.compasspathways.com/News--Events-/news/news-details/2021/COMPASS-Pathways-announces-positive-outcome-of-25mg-COMP360-psilocybin-therapy-as-adjunct-to-SSRI-antidepressants-in-open-label-treatment-resistant-depression-study/default.aspx?utm_source=chatgpt.com
1 · Reply
putINwork
putINwork Sep. 19 at 7:37 PM
$CMPS $HELP once again I’m not looking at fireside chats or their website - I’m looking at TRIAL DESIGN AND ENROLLMENT WHICH THE FDA BASIS DRUG DOSING AND IMPLEMENTATION ON!!! HELP has no need for washout and is kinetically more stable - why would you want a 6 hr clinic time versus a 2 hr clinic time?!!!!!! EVEN IF CMPS could be tried with antidepressants why on earth would you prefer a 6hr clinic time?!! 🤣🤣🤣🤣 versus a 2 hour time?!!! Read the design of the trials themselves, that’s all I’m going to say. Yes, you do need to undergo a washout period and stop taking your current antidepressant to participate in standard trials for Compass Pathways' (CMPS) psilocybin treatment (COMP360).Unlike Cybin’s add-on approach, Compass Pathways has historically designed its pivotal clinical trials—including its major COMP005 and COMP006 Phase 3 trials for Treatment-Resistant Depression (TRD)—around the use of COMP360 as a monotherapy.
3 · Reply
Millionaire11
Millionaire11 Sep. 19 at 7:32 PM
$CMPS $HELP “Patients taking COMP360 psilocybin with concomitant SSRIs showed comparable treatment outcomes to patients withdrawn from their SSRI therapy in COMPASS’s phase IIb trial All patients tolerated COMP360 psilocybin therapy well“ reading must be hard. https://ir.compasspathways.com/News--Events-/news/news-details/2021/COMPASS-Pathways-announces-positive-outcome-of-25mg-COMP360-psilocybin-therapy-as-adjunct-to-SSRI-antidepressants-in-open-label-treatment-resistant-depression-study/default.aspx?utm_source=chatgpt.com
0 · Reply
putINwork
putINwork Sep. 19 at 7:31 PM
$CMPS $HELP Stop misleading people!!! HELP you can stay on your antidepressant and clinic times are shorter. CMPS you need to fully wash out which many patients won’t do. Yes, you do need to undergo a washout period and stop taking your current antidepressant to participate in standard trials for Compass Pathways' (CMPS) psilocybin treatment (COMP360).Unlike Cybin’s add-on approach, Compass Pathways has historically designed its pivotal clinical trials—including its major COMP005 and COMP006 Phase 3 trials for Treatment-Resistant Depression (TRD)—around the use of COMP360 as a monotherapy.Why Compass Pathways Requires a WashoutPreventing Drug Interactions: Traditional antidepressants (like SSRIs or SNRIs) alter serotonin receptors in the brain. Because psilocybin also targets these exact same receptors, being on an antidepressant can significantly blunt or completely block the therapeutic effects of the psychedelic.
3 · Reply
Millionaire11
Millionaire11 Sep. 19 at 7:29 PM
$CMPS $HELP read https://ir.compasspathways.com/News--Events-/news/news-details/2021/COMPASS-Pathways-announces-positive-outcome-of-25mg-COMP360-psilocybin-therapy-as-adjunct-to-SSRI-antidepressants-in-open-label-treatment-resistant-depression-study/default.aspx?utm_source=chatgpt.com
0 · Reply
putINwork
putINwork Sep. 19 at 7:27 PM
$CMPS $HELP Well did you even read the trial design of of CMPS?! Seems like you are wrong. Patients need a complete washout before starting and approval mimics what was studied in the trial not some speculative chat you mention
0 · Reply
Latest News on HELP
Helus Pharma initiated with an Overweight at Barclays

2026-09-18T13:01:13.000Z - 2 days ago

Helus Pharma initiated with an Overweight at Barclays

Cybin Transcript: Morgan Stanley 24th Annual Global Healthcare Conference

Sep 16, 2026, 8:30 AM EDT - 4 days ago

Cybin Transcript: Morgan Stanley 24th Annual Global Healthcare Conference

Cybin Transcript: H.C. Wainwright 28th Annual Global Investment Conference

Sep 14, 2026, 9:00 AM EDT - 6 days ago

Cybin Transcript: H.C. Wainwright 28th Annual Global Investment Conference

Cybin Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference

Sep 11, 2026, 8:00 AM EDT - 9 days ago

Cybin Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference

Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York

Sep 10, 2026, 7:30 AM EDT - 10 days ago

Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York

Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York

Sep 9, 2026, 7:30 AM EDT - 11 days ago

Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York

Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York

Sep 3, 2026, 7:30 AM EDT - 17 days ago

Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York

Helus Pharma price target raised to $62 from $8 at TD Cowen

2026-08-20T11:40:59.000Z - 4 weeks ago

Helus Pharma price target raised to $62 from $8 at TD Cowen

Helus Pharma appoints Regina Donohue as chief people officer

2026-08-18T11:35:22.000Z - 4 weeks ago

Helus Pharma appoints Regina Donohue as chief people officer

Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board

Aug 18, 2026, 7:30 AM EDT - 4 weeks ago

Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board

Cybin Earnings release: Q1 2027

Aug 14, 2026, 4:00 PM EDT - 5 weeks ago

Cybin Earnings release: Q1 2027

Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights

Aug 14, 2026, 7:28 AM EDT - 5 weeks ago

Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights

Cybin Transcript: Canaccord Genuity's 46th Annual Growth Conference

Aug 12, 2026, 12:00 PM EDT - 5 weeks ago

Cybin Transcript: Canaccord Genuity's 46th Annual Growth Conference

Helus Pharma appoints Michael Halstead as CEO

2026-08-05T14:38:41.000Z - 6 weeks ago

Helus Pharma appoints Michael Halstead as CEO

Helus Pharma Appoints Michael Halstead as Chief Executive Officer

Aug 3, 2026, 7:40 AM EDT - 6 weeks ago

Helus Pharma Appoints Michael Halstead as Chief Executive Officer

Helus Pharma initiated with an Overweight at Wells Fargo

2026-07-27T09:20:12.000Z - 7 weeks ago

Helus Pharma initiated with an Overweight at Wells Fargo

Helus Pharma completes enrollment in Phase 3 APPROACH study of HLP003

2026-07-21T15:05:31.000Z - 2 months ago

Helus Pharma completes enrollment in Phase 3 APPROACH study of HLP003

Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule

Jul 21, 2026, 7:50 AM EDT - 2 months ago

Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule

Helus Pharma price target lowered to $45 from $48 at Guggenheim

2026-07-17T11:10:24.000Z - 2 months ago

Helus Pharma price target lowered to $45 from $48 at Guggenheim

ATAI GHRS LLY

Helus Pharma price target lowered to $15 from $30 at Alliance Global

2026-07-14T13:41:08.000Z - 2 months ago

Helus Pharma price target lowered to $15 from $30 at Alliance Global

Psychedelic: Compass Pathways reports six-month data for psilocybin drug

2026-07-09T13:50:15.000Z - 2 months ago

Psychedelic: Compass Pathways reports six-month data for psilocybin drug

ATAI CMND CMPS DFTX

Helus Pharma price target lowered to $70 from $95 at H.C. Wainwright

2026-07-09T10:05:14.000Z - 2 months ago

Helus Pharma price target lowered to $70 from $95 at H.C. Wainwright

Helus Pharma price target lowered to $42 from $45 at Canaccord

2026-07-01T10:40:45.000Z - 2 months ago

Helus Pharma price target lowered to $42 from $45 at Canaccord

Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results

Jun 29, 2026, 7:40 AM EDT - 2 months ago

Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results

Cybin Annual report: Q4 2026

Jun 29, 2026, 7:00 AM EDT - 2 months ago

Cybin Annual report: Q4 2026

Cybin Earnings release: Q4 2026

Jun 29, 2026, 7:00 AM EDT - 2 months ago

Cybin Earnings release: Q4 2026

Cybin Slides: Corporate presentation

Jun 29, 2026, 7:00 AM EDT - 2 months ago

Cybin Slides: Corporate presentation

Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering

Jun 25, 2026, 9:27 AM EDT - 2 months ago

Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering

Helus Pharma™ Announces US$50 Million Underwritten Offering

Jun 24, 2026, 6:01 AM EDT - 2 months ago

Helus Pharma™ Announces US$50 Million Underwritten Offering

Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress

Jun 24, 2026, 6:00 AM EDT - 2 months ago

Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress

Cybin Transcript: 7th Annual HCW Neuro Perspectives Hybrid Conference

Jun 15, 2026, 7:00 AM EDT - 3 months ago

Cybin Transcript: 7th Annual HCW Neuro Perspectives Hybrid Conference

Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference

Jun 11, 2026, 7:30 AM EDT - 3 months ago

Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference

Cybin Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 2:35 PM EDT - 3 months ago

Cybin Transcript: Jefferies Global Healthcare Conference 2026

Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York

Jun 1, 2026, 7:30 AM EDT - 3 months ago

Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York

CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health

Apr 30, 2026, 7:17 PM EDT - 4 months ago

CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health

Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference

Apr 30, 2026, 7:30 AM EDT - 4 months ago

Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference

Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health

Apr 28, 2026, 7:30 AM EDT - 4 months ago

Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health

Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan

Apr 23, 2026, 7:30 AM EDT - 5 months ago

Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan

How Trump's psychedelics executive order could unlock stalled cannabis reform

Apr 20, 2026, 2:05 PM EDT - 5 months ago

How Trump's psychedelics executive order could unlock stalled cannabis reform

ATAI CMPS DFTX GHRS

Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions

Apr 20, 2026, 8:15 AM EDT - 5 months ago

Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions

Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer

Apr 20, 2026, 8:00 AM EDT - 5 months ago

Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer

Psychedelic drug makers rally as Trump orders FDA to expedite reviews

Apr 20, 2026, 6:43 AM EDT - 5 months ago

Psychedelic drug makers rally as Trump orders FDA to expedite reviews

ATAI CMPS DFTX ENVB GHRS

Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs

Apr 16, 2026, 7:30 AM EDT - 5 months ago

Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs

Cybin Slides: Corporate presentation

Mar 27, 2026, 8:00 AM EDT - 5 months ago

Cybin Slides: Corporate presentation

Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer

Mar 12, 2026, 7:30 AM EDT - 6 months ago

Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer

Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder

Mar 5, 2026, 7:30 AM EST - 6 months ago

Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder

Cybin Transcript: Study result

Mar 5, 2026, 7:30 AM EST - 6 months ago

Cybin Transcript: Study result

Cybin Press release: Study result

Mar 5, 2026, 7:30 AM EST - 6 months ago

Cybin Press release: Study result

Cybin Slides: Study result

Mar 5, 2026, 7:30 AM EST - 6 months ago

Cybin Slides: Study result

Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee

Feb 24, 2026, 7:45 AM EST - 6 months ago

Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee

Nature Medicine Publishes Helus Pharma's Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder

Feb 17, 2026, 7:30 AM EST - 7 months ago

Nature Medicine Publishes Helus Pharma's Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder

Cybin Earnings release: Q3 2026

Feb 13, 2026, 12:30 PM EST - 7 months ago

Cybin Earnings release: Q3 2026

HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

Feb 13, 2026, 7:31 AM EST - 7 months ago

HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

Cybin Initiates At-The-Market Equity Program of up to US$100 Million

Dec 30, 2025, 3:33 PM EST - 8 months ago

Cybin Initiates At-The-Market Equity Program of up to US$100 Million

Cybin Registration statement: Registration Filing

Dec 19, 2025, 7:00 AM EST - 9 months ago

Cybin Registration statement: Registration Filing

Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq

Dec 18, 2025, 12:29 PM EST - 9 months ago

Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq

Cybin Transcript: Jefferies London Healthcare Conference 2025

Nov 17, 2025, 7:30 AM EST - 10 months ago

Cybin Transcript: Jefferies London Healthcare Conference 2025

Cybin Earnings Call Transcript: Q2 2026

Nov 13, 2025, 8:00 AM EST - 10 months ago

Cybin Earnings Call Transcript: Q2 2026

Cybin Earnings release: Q2 2026

Nov 13, 2025, 8:00 AM EST - 10 months ago

Cybin Earnings release: Q2 2026

Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

Nov 13, 2025, 7:20 AM EST - 10 months ago

Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

Cybin to Participate in the Jefferies Global Healthcare Conference in London

Nov 12, 2025, 7:30 AM EST - 10 months ago

Cybin to Participate in the Jefferies Global Healthcare Conference in London

Cybin Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Nov 10, 2025, 4:30 PM EST - 10 months ago

Cybin Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025

Nov 6, 2025, 7:30 AM EST - 10 months ago

Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025

Cybin Transcript: Future of Health Summit 2025

Nov 5, 2025, 2:00 PM EST - 10 months ago

Cybin Transcript: Future of Health Summit 2025

Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Nov 5, 2025, 7:30 AM EST - 10 months ago

Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Cybin to Participate at the 2025 Milken Institute Future of Health Summit

Nov 3, 2025, 7:30 AM EST - 10 months ago

Cybin to Participate at the 2025 Milken Institute Future of Health Summit

Cybin Announces Closing of $175 Million Registered Direct Offering

Oct 31, 2025, 4:19 PM EDT - 10 months ago

Cybin Announces Closing of $175 Million Registered Direct Offering

Cybin Announces $175 Million Registered Direct Offering

Oct 28, 2025, 8:00 AM EDT - 10 months ago

Cybin Announces $175 Million Registered Direct Offering

BetterLife Pharma Appoints Doug Drysdale as Corporate Advisor

Oct 21, 2025, 8:00 AM EDT - 11 months ago

BetterLife Pharma Appoints Doug Drysdale as Corporate Advisor

Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones

Sep 23, 2025, 5:00 PM EDT - 12 months ago

Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones

Cybin Transcript: TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

Sep 17, 2025, 9:20 AM EDT - 1 year ago

Cybin Transcript: TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

Cybin Registration statement: Registration Filing

Sep 17, 2025, 8:00 AM EDT - 1 year ago

Cybin Registration statement: Registration Filing

Cybin to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

Sep 11, 2025, 7:30 AM EDT - 1 year ago

Cybin to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

Cybin Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 11:00 AM EDT - 1 year ago

Cybin Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder

Sep 8, 2025, 7:30 AM EDT - 1 year ago

Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder

Cybin Transcript: Cantor Global Healthcare Conference 2025

Sep 5, 2025, 10:20 AM EDT - 1 year ago

Cybin Transcript: Cantor Global Healthcare Conference 2025

Cybin to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 7:30 AM EDT - 1 year ago

Cybin to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Cybin to Participate in the Cantor Global Healthcare Conference 2025

Sep 3, 2025, 7:30 AM EDT - 1 year ago

Cybin to Participate in the Cantor Global Healthcare Conference 2025

Cybin Announces Senior Leadership Changes

Sep 2, 2025, 7:30 AM EDT - 1 year ago

Cybin Announces Senior Leadership Changes

Cybin Receives Australian Approval for EMBRACE, a Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder

Aug 26, 2025, 7:30 AM EDT - 1 year ago

Cybin Receives Australian Approval for EMBRACE, a Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder

Cybin Announces Results of Annual Meeting of Shareholders

Aug 18, 2025, 5:30 PM EDT - 1 year ago

Cybin Announces Results of Annual Meeting of Shareholders

Cybin Transcript: AGM 2025

Aug 18, 2025, 10:00 AM EDT - 1 year ago

Cybin Transcript: AGM 2025

Cybin Reports Important Progress on Key Milestones and First Quarter Fiscal Year 2026 Financial Results

Aug 13, 2025, 5:30 PM EDT - 1 year ago

Cybin Reports Important Progress on Key Milestones and First Quarter Fiscal Year 2026 Financial Results

BloomBoom
BloomBoom Sep. 20 at 2:25 PM
$HELP Zero washout w/ a max 2hr treatment window vs 6 in cmps & required togo cold turkey off old meds. half the market cap of $CMPS and up only 100% ytd vs cmps @200% ytd. only a wouldn’t know how to play this one.
3 · Reply
RuddyRolls
RuddyRolls Sep. 20 at 2:34 AM
$CMPS $HELP @Millionaire11 @putINwork Thanks Brad, Emily, Alan Watts, Edward De Bono, Terence McKenna & The Mushroom! "The western mind is highly trained in rational, dualistic thinking, a lineage that traces itself all the way back to the ancient Greeks. Dualistic thinking is about comparison, differentiation, and splitting apart; in essence, it views the world as either this or that. It is an extremely important quality—one that underlies modern science and all the awesome, life-enhancing discoveries it has bequeathed us. But dualistic thinking is not the way only way to make sense of the world. And when it is applied to everything, we tend to run into problems. Some things in life truly are either-or, but many are both-and. Ancient wisdom traditions such as Buddhism and Taoism understand and teach the paradoxical nature of reality. They develop a non-dual mind." https://thegrowtheq.com/a-new-way-of-thinking-not-either-or-both-and/ https://www.carrienassifphd.com/blog/bothand
2 · Reply
JusaVaan
JusaVaan Sep. 19 at 9:55 PM
$CMPS $HELP I believe you are wrong about $HELP 2-hour clinic time. $ATAI 5-meo-dmt has a 2 hours clinic time. I believe $HELP has said it could be about 4 hours.
1 · Reply
Millionaire11
Millionaire11 Sep. 19 at 7:52 PM
$CMPS I’m sorry for getting argumentative. I want everybody to make money. I just like sharing my DD. I believe $HELP will do just fine. $CMPS is my bet and to me it is the obvious choice and i like to share my logic. I could be very wrong. In the end of the day our silly debates on stocktwits will not move the stock price. I wish everybody the best and good luck @putINwork I think you will do just fine in $HELP let’s win together.
2 · Reply
Millionaire11
Millionaire11 Sep. 19 at 7:38 PM
$CMPS $HELP I posted an article from their trial. Here ill post it again. https://ir.compasspathways.com/News--Events-/news/news-details/2021/COMPASS-Pathways-announces-positive-outcome-of-25mg-COMP360-psilocybin-therapy-as-adjunct-to-SSRI-antidepressants-in-open-label-treatment-resistant-depression-study/default.aspx?utm_source=chatgpt.com
1 · Reply
putINwork
putINwork Sep. 19 at 7:37 PM
$CMPS $HELP once again I’m not looking at fireside chats or their website - I’m looking at TRIAL DESIGN AND ENROLLMENT WHICH THE FDA BASIS DRUG DOSING AND IMPLEMENTATION ON!!! HELP has no need for washout and is kinetically more stable - why would you want a 6 hr clinic time versus a 2 hr clinic time?!!!!!! EVEN IF CMPS could be tried with antidepressants why on earth would you prefer a 6hr clinic time?!! 🤣🤣🤣🤣 versus a 2 hour time?!!! Read the design of the trials themselves, that’s all I’m going to say. Yes, you do need to undergo a washout period and stop taking your current antidepressant to participate in standard trials for Compass Pathways' (CMPS) psilocybin treatment (COMP360).Unlike Cybin’s add-on approach, Compass Pathways has historically designed its pivotal clinical trials—including its major COMP005 and COMP006 Phase 3 trials for Treatment-Resistant Depression (TRD)—around the use of COMP360 as a monotherapy.
3 · Reply
Millionaire11
Millionaire11 Sep. 19 at 7:32 PM
$CMPS $HELP “Patients taking COMP360 psilocybin with concomitant SSRIs showed comparable treatment outcomes to patients withdrawn from their SSRI therapy in COMPASS’s phase IIb trial All patients tolerated COMP360 psilocybin therapy well“ reading must be hard. https://ir.compasspathways.com/News--Events-/news/news-details/2021/COMPASS-Pathways-announces-positive-outcome-of-25mg-COMP360-psilocybin-therapy-as-adjunct-to-SSRI-antidepressants-in-open-label-treatment-resistant-depression-study/default.aspx?utm_source=chatgpt.com
0 · Reply
putINwork
putINwork Sep. 19 at 7:31 PM
$CMPS $HELP Stop misleading people!!! HELP you can stay on your antidepressant and clinic times are shorter. CMPS you need to fully wash out which many patients won’t do. Yes, you do need to undergo a washout period and stop taking your current antidepressant to participate in standard trials for Compass Pathways' (CMPS) psilocybin treatment (COMP360).Unlike Cybin’s add-on approach, Compass Pathways has historically designed its pivotal clinical trials—including its major COMP005 and COMP006 Phase 3 trials for Treatment-Resistant Depression (TRD)—around the use of COMP360 as a monotherapy.Why Compass Pathways Requires a WashoutPreventing Drug Interactions: Traditional antidepressants (like SSRIs or SNRIs) alter serotonin receptors in the brain. Because psilocybin also targets these exact same receptors, being on an antidepressant can significantly blunt or completely block the therapeutic effects of the psychedelic.
3 · Reply
Millionaire11
Millionaire11 Sep. 19 at 7:29 PM
$CMPS $HELP read https://ir.compasspathways.com/News--Events-/news/news-details/2021/COMPASS-Pathways-announces-positive-outcome-of-25mg-COMP360-psilocybin-therapy-as-adjunct-to-SSRI-antidepressants-in-open-label-treatment-resistant-depression-study/default.aspx?utm_source=chatgpt.com
0 · Reply
putINwork
putINwork Sep. 19 at 7:27 PM
$CMPS $HELP Well did you even read the trial design of of CMPS?! Seems like you are wrong. Patients need a complete washout before starting and approval mimics what was studied in the trial not some speculative chat you mention
0 · Reply
Millionaire11
Millionaire11 Sep. 19 at 7:26 PM
$CMPS $HELP @putINwork man can you read. There is no need to stop your antidepressants with COMP360 either in fact it is proven to work with and with out antidepressants. HELP only is proven to work with. There is an obvious difference in which is the better study.
0 · Reply
putINwork
putINwork Sep. 19 at 7:23 PM
$CMPS $HELP What would I invest in??? The drug that’s going to be much much more practical for use in Psychiatry which is HELP = SHORTER CLINIC TIMES 2hrs vs 6 due to deuterated psilocybin and NO NEED TO STOP YOUR ANTIDEPRESSANT- AND NO MEDS CURRENTLY SPECIFICALLY FOR TREATMENT RESISTANT DEPRESSION which is highly prevalent. I’m bullish on both but in the near term HELP has phase 3 data that is based on FDA breakthrough designation. It also has a much more KINETICALLY STABLE deuterated psilocybin (meaning clinic times are 2 hours not 6 which is huge for patient care). HELP is being studied as an ADD ON to current antidepressant regimens - NO NEED TO STOP YOUR ANTIDEPRESSANT (which can be really scary to anyone on one).
1 · Reply
MurseOMoney
MurseOMoney Sep. 19 at 7:46 AM
$TRUFF Still unsure why this PHASE 3 study isn’t getting more heat 🌬️🔥 $CMPS $DFTX $ATAI $HELP
5 · Reply
Millionaire11
Millionaire11 Sep. 19 at 2:41 AM
$CMPS $HELP both will succeed but one has a full market almost to themselves not even including ptsd coming up which hasn’t had an approved medicine in almost 30 years. This is two untapped minimal competition indications and the other has competitors everywhere. $CMPS is trd - untapped - only 2% of TRD patients are being treated. $HELP is MDD. Not competing with one another.
0 · Reply
Millionaire11
Millionaire11 Sep. 19 at 2:15 AM
$CMPS this is my last time. Listen to recent fire side chat. COMP360 works without SSRI’s and it is proven to. It also has been studied with SSRI it also works. $HELP is only being studied for the mixed use.Which one would you rather invest in? One that is going to be approved for both or one that is going to be approved specifically with SSRI’s. COMP is a 6 hour treatment. Very predictable and very stable. HELP is a 2 hour treatment. Yes it is a faster experience but clinics will need a higher turn over to make money. All this is with MDD something that already has 50+ drugs on the market. Would you rather give a patient a pill first or any of the other 50+ treatments that are less burdensome or through them into a psychedelic trip. COMPis for TRD. One six hour trip, clinics get paid for 6 hours. If I’m operating a clinic I’m pushing that every time. All this to say HELP and CMPS arent even competitors. CMPS is going to be the second treatment available for TRD. HELP will be 1 of 50.
1 · Reply
efficiency
efficiency Sep. 18 at 11:04 PM
$HELP Trend has been strong since late June. Grow a pair.
0 · Reply
JreadyTOTHEMOON
JreadyTOTHEMOON Sep. 18 at 9:24 PM
$HELP my cmps shares closed over 15 today and this shit needs HELP
0 · Reply
RuddyRolls
RuddyRolls Sep. 18 at 8:41 PM
$CMPS $HELP Very simplistic. HELP is a binary on its pending phase 3 read out. It has vastly more upside on very strong to knock out data and more downside on weak data - At This Stage. CMPS is a known known. It's simply a valuation question after the almost inevitable FDA approval and market dynamics. (A far SAFER bet - which is, I suspect, fundamentally why you missed the 167 per cent run on HELP in the last 3 months while continually banging the CMPS drum the entire time for a mere 24 per cent). The product is at bottom the same. Maybe try some (in a safe setting 😂). A single religious grade mystical experience is said to move one an entire standard deviation on the Openness continuum on the Big 5 Personality Test - with some serious durability. That could HELP with the CMPS Fundamentalism and open you up to a BOTH/ AND opportunity. https://youtu.be/wLc_MC7NQek?t=9132&si=u-GQ048XaaI3a8oK https://bigfive-test.com/
1 · Reply
Solomonwisdom7
Solomonwisdom7 Sep. 18 at 8:02 PM
$HELP ChatGTP analysis at the close: HELP had just reached a new 52-week high, so profit-taking after the recent run-up is plausible. Today's $15.15 open was also the new intraday high before the reversal.
1 · Reply
jdunlap76
jdunlap76 Sep. 18 at 7:47 PM
$HELP Curious to see if we get any meaningful price movement after hours with Opex and it being Friday.
0 · Reply
RuddyRolls
RuddyRolls Sep. 18 at 7:44 PM
$HELP curious. Pinning to the $12.50 strike for OpEx it seems. Monday will probably reverse the whole day in one day. HELP traded 4.9m shares CMPS traded 2.7m shares Lot of cheap shares in new hands today.
0 · Reply
JPine26
JPine26 Sep. 18 at 7:44 PM
$HELP me
0 · Reply